| payload |
{"created_at":"2026-04-17T21:52:12.771 {"created_at":"2026-04-17T21:52:12.771882+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/what-309k-kiniksa-insider-sale-might-signal-amid-120-stock-surge","value":{"fp":"880f96058440bd80","kind":"unusual_volume","published_at":"2026-04-17T21:16:54+00:00","source":"Nasdaq Markets","summary":"Key PointsThe chief accounting officer of Kiniksa Pharmaceuticals sold 6,625 shares for roughly $309,000 on April 9, 2026.","tickers":[],"title":"What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge","url":"https://www.nasdaq.com/articles/what-309k-kiniksa-insider-sale-might-signal-amid-120-stock-surge"}}... |